Breast Cancer Clinical Trial 2018-018CIRB

[LCID Study Number: 2018-018CIRB]

NRG-BR005: A Phase II Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients With Clinical/Radiologic Complete Response After Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment Without Surgery

The purpose of this study is to look at tumor tissue collected from a biopsy done before breast surgery to check if the chemotherapy that patients received destroyed their breast cancer cells.

Disease/Condition: Breast Cancer

Department: Hematology and Oncology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421

View NCT ID 03188393 on ClinicalTrials.gov
Protocol #: 2018-018CIRB
Principal Investigator(s): Corrine Zarwan
Study Coordinator(s): Julia Roache
Trial Phase: Sponsor Initiated Study Phase 2